Preserving the Practice of Urology in California Since 1986
Frontlines
CUA Synopsis: AUA Advocacy Summit Summary 2019
By CUA Secretary, Dr. John Lam By Dr. John Lam, CUA Secretary The following is a comprehensive summary of the…
Read More
CUA Past-President to Lead AUA Public Policy Council
The CUA is proud to announce that Dr. Eugene Rhee, CUA past-president (2009-2013), has been appointed as chair of the…
Read MoreCMA: 12 ways to be a physician advocate
Article from the CMA Newswire. To help physicians improve advocacy efforts on behalf of patients, CMA has published this helpful…
Read MoreCUA supports proposed HHS rule for fixing drug rebates
Drug discounts should be benefitting beneficiaries—not drug industry middlemen. Trump Administration Proposes to Lower Drug Costs by Targeting Backdoor Rebates…
Read MoreSB 201: CUA Pres. debates InterAct on Radio Show
Should CA ban nonconsensual ‘medically unnecessary’ surgery on intersex minors? Click the link below to read the full article and…
Read More
New Laws 2019: What physicians need to know
To help physicians understand the most significant new health laws, CMA has published its annual new laws round up. Click…
Read More
Peter Bretan Elected CMA President-Elect
A huge win for urology in a run-off election at the CMA HOD presidential election October 14, 2018: The CUA…
Read MoreCUA endorses Peter Bretan for CMA President
1 1 The CUA strongly supports Dr. Bretan as a knowledgeable physician representative and staunch advocate of the sanctity of…
Read MoreCMA survey finds rampant health plan payment abuses
1 {{unknown}} 1 Last month, CMA, along with its county medical societies and several specialty societies, surveyed physicians to obtain…
Read More
There are several bipartisan federal policy proposals, like #HR4597 and #HR6179, cosponsored by CA representatives, that promote increased use of #biosimilars to benefit patients, providers, and budgets while preserving physician and patient choice.
Excellent panel at @SDChamber today discussing health care cost-savings possibilities like #biosimilars. CA has the potential to save hundreds of millions of dollars annually by increasing access to biosimilar medicines in the state.
First participants dosed with potential vaccine for COVID19 in @Pfizer clinical trials https://tinyurl.com/y7zc8yhy
Flash poll on delayed surgeries - 5 super quick questions - please click link and let us know. Results shown at end.
https://www.surveymonkey.com/r/Z95NT37
An erectile dysfunction drug might improve critical coronavirus cases https://bgr.com/2020/04/01/coronavirus-cure-erectile-dysfunction-drug-aviptadil-used-in-trial/
Great read in @MorningConsult on how #biosimilars can help patients afford their medications ➡️ "Affordable biosimilars could be used to treat some of the most complex diseases we know while increasing competition in the health care marketplace." https://morningconsult.com/opinions/policy-pathway-expanding-access-more-affordable-treatments-americans/
Coronavirus: The Hammer and the Dance
https://link.medium.com/gIH5T8WBZ4
@tomaspueyo
An excellent synopsis and action plan to buy us some time. See charts showing impact on our healthcare system.
The future of R&D is at risk because of #HR3. Congress must reject this proposal, so future treatment innovations are available to the patients who need them the most. @HouseGOP @HouseDemocrats
CUA President, Dr. Peter Bretan, taking the podium as newly installed CMA President, on Sat., 10/26/19, Anaheim, CA. The energy and vibe was positively amazing!
"Physicians must lead the fight to take back our profession from administrators and bureaucrats." -- PB